|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-6-22
|
|
pubmed:abstractText |
The aim of the present study was to determine the clinical usefulness of nuclear matrix protein 22 (NMP22) as a new urinary marker for the screening of urothelial cancer in patients with microscopic hematuria, especially in comparison with that of voided urine cytology.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0919-8172
|
|
pubmed:author |
pubmed-author:AkazaHH,
pubmed-author:FujitaKK,
pubmed-author:HiraoYY,
pubmed-author:IshikawaSS,
pubmed-author:KawabeKK,
pubmed-author:KoisoKK,
pubmed-author:KotakeTT,
pubmed-author:KubotaYY,
pubmed-author:KumazawaJJ,
pubmed-author:MiyanagaNN,
pubmed-author:NoguchiRR,
pubmed-author:ObataKK,
pubmed-author:OhmoriHH,
pubmed-author:OhtaniMM,
pubmed-author:TsukamotoTT
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
173-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10226833-Adult,
pubmed-meshheading:10226833-Aged,
pubmed-meshheading:10226833-Aged, 80 and over,
pubmed-meshheading:10226833-Cystitis,
pubmed-meshheading:10226833-Diagnosis, Differential,
pubmed-meshheading:10226833-Female,
pubmed-meshheading:10226833-Hematuria,
pubmed-meshheading:10226833-Humans,
pubmed-meshheading:10226833-Male,
pubmed-meshheading:10226833-Mass Screening,
pubmed-meshheading:10226833-Middle Aged,
pubmed-meshheading:10226833-Nuclear Proteins,
pubmed-meshheading:10226833-Prostatic Hyperplasia,
pubmed-meshheading:10226833-Prostatic Neoplasms,
pubmed-meshheading:10226833-Tumor Markers, Biological,
pubmed-meshheading:10226833-Urinalysis,
pubmed-meshheading:10226833-Urinary Bladder Neoplasms,
pubmed-meshheading:10226833-Urinary Calculi,
pubmed-meshheading:10226833-Urothelium
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria.
|
|
pubmed:affiliation |
University of Tsukuba, Japan.
|
|
pubmed:publicationType |
Journal Article
|
